- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Karsinom, melanom in China
Totalt 5298 resultater
-
Shandong TheraWisdom Biopharma Co., Ltd.RekrutteringAvansert melanom | Avansert urotelialt karsinomKina
-
Eye & ENT Hospital of Fudan UniversityCancer Institute and Hospital, Chinese Academy of Medical SciencesRekrutteringSlimhinne melanom | Sinonasalt melanomKina
-
Qilu Pharmaceutical Co., Ltd.RekrutteringMelanom | Urotelialt karsinomKina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.UkjentAvansert akralt malignt melanomKina
-
Shanghai Junshi Bioscience Co., Ltd.UkjentMetastatisk melanom | Avansert melanomKina
-
Innovent Biologics (Suzhou) Co. Ltd.AvsluttetAkralt melanom som er fjernet ved kirurgiKina
-
Qilu Hospital of Shandong UniversityHar ikke rekruttert ennåLokalt avansert eller metastatisk akralt malignt melanomKina
-
Peking University Cancer Hospital & InstituteRekruttering
-
Fudan UniversityRekruttering
-
Peking University Cancer Hospital & InstituteRekrutteringSlimhinne melanomKina
-
Peking University Cancer Hospital & InstituteUkjent
-
Peking University Cancer Hospital & InstituteRekruttering
-
Jiangsu HengRui Medicine Co., Ltd.Fullført
-
OrienGene Biotechnology Ltd.Ukjent
-
Peking University Cancer Hospital & InstituteUkjentAvansert melanomKina
-
Henan Cancer HospitalRekrutteringAvansert melanomKina
-
First Affiliated Hospital of Zhejiang UniversityRekruttering
-
Timmune Biotech Inc.The Second Affiliated Hospital of Hainan Medical University; Hainan Cancer...Ukjent
-
Sun Yat-sen UniversityUkjent
-
Henan Cancer HospitalJiangsu HengRui Medicine Co., Ltd.Ukjent
-
Peking UniversityNovartisFullførtMetastatisk melanomKina
-
Fudan UniversityZhejiang Cancer Hospital; Fujian Cancer Hospital; The Affiliated Nanjing...Rekruttering
-
Peking University Cancer Hospital & InstituteRekrutteringSlimhinne melanomKina
-
Shanghai Junshi Bioscience Co., Ltd.Aktiv, ikke rekrutterende
-
AnewPharmaUkjentSlimhinne melanomKina
-
Peking University Cancer Hospital & InstituteUkjent
-
RemeGen Co., Ltd.RekrutteringAvansert melanom | Melanom, stadium II | HER2-positivKina
-
Shanghai Junshi Bioscience Co., Ltd.Aktiv, ikke rekrutterendeMetastatisk melanom | Uopererbart melanomKina
-
Di WuRekrutteringAkralt melanomKina
-
Hoffmann-La RocheFullført
-
Shanghai Junshi Bioscience Co., Ltd.UkjentAvansert melanom | Nyrekreft stadium IvKina
-
Fudan UniversityUkjentMelanom stadium IIIB-IVKina
-
Simcere Pharmaceutical Co., LtdUkjentAvansert melanom | Ubehandlede pasienterKina
-
Yong ChenHar ikke rekruttert ennå
-
Fujian Cancer HospitalPåmelding etter invitasjon
-
Peking University Cancer Hospital & InstituteHar ikke rekruttert ennåSlimhinne melanom | Neoadjuvant behandlingKina
-
Peking University Cancer Hospital & InstituteHar ikke rekruttert ennåMelanom | Metastatisk melanom | Slimhinne melanomKina
-
Eye & ENT Hospital of Fudan UniversityCancer Institute and Hospital, Chinese Academy of Medical SciencesRekrutteringOndartet melanom | Sinonasalt melanomKina
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.Department of Immunology, The Fourth Hospital of Hebei Medical UniversityRekrutteringOndartet melanom, lungekreft eller tykktarmskreftKina
-
Shanghai Henlius BiotechRekruttering
-
Fudan UniversityRekrutteringKlinisk stadium III kutant melanom AJCC v8 | Klinisk stadium IV kutant melanom AJCC v8Kina
-
Nanjing Leads Biolabs Co.,LtdRekruttering
-
Xiangya Hospital of Central South UniversityUkjent
-
Henan Cancer HospitalUkjentAvansert kreft | Slimhinne melanom | Apatinib | SHR-1210Kina
-
Peking University Cancer Hospital & InstituteRekrutteringMelanom | Temozolomid | Apatinib | Camrelizumab | Akralt melanom | Neoadjuvans | Patologisk responsKina
-
Zai Lab (Shanghai) Co., Ltd.AvsluttetUoperabelt, tilbakevendende eller metastatisk melanom | Ubehandlet slimhinne eller akral lentiginøst melanomKina
-
The Affiliated Hospital of Qingdao UniversityRekrutteringGynekologisk kreft | Thoraxkreft | Ondartet melanom | BuksvulsterKina
-
Eucure (Beijing) Biopharma Co., LtdRekruttering
-
AmgenFullførtIkke-opererbart stadium IIIB-IV Malignt melanomJapan
-
Peking University Cancer Hospital & InstituteUkjentAvansert slimhinnemelanomKina